AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Mirum Pharmaceuticals, Inc.

$85.00 +$6.93 (+8.88%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$86.39
Day Range
$84.11$86.75
Year Range
$63.23$130.00
Market Cap
5.52B
AVG Volume
749.96K
Trailing/Forward PE
-5.84/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MIRM Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2618.07M
26 Q1569.61M
25 Q4521.31M
25 Q3471.79M
25 Q2429.16M
25 Q1379.25M
24 Q4336.89M
24 Q3307.03M
24 Q2264.38M
24 Q1224M
Net Income (USD) · TTM
-1B-750M-500M-250M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MIRM Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-860.21M
26 Q1-798.84M
25 Q4-23.36M
25 Q3-41.42M
25 Q2-58.56M
25 Q1-77.34M
24 Q4-87.94M
24 Q3-99.81M
24 Q2-109.16M
24 Q1-158.56M
Operating Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MIRM Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-107.66M
26 Q1-70.12M
25 Q4-22.14M
25 Q3-41.79M
25 Q2-57.08M
25 Q1-76.32M
24 Q4-87.61M
24 Q3-95.97M
24 Q2-108.43M
24 Q1-108.47M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: MIRM

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Mirum Pharmaceuticals, Inc.
MIRM
Stockpicker

Video analysis: MIRM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MIRM

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.